随着全世界老龄化的进展, 外周动脉疾病(peripheral arterial diseases, PAD) 的患病率逐渐上升,
PAD 与糖尿病, 高血脂, 高血压, 吸烟等危险因素密切相关; PAD 患者通常有广泛的动脉粥样硬化 …

Lower extremity arteries might be affected by atherosclerotic peripheral arterial disease
(PAD), or by embolization causing ischaemic symptoms. Patients with PAD often have …

Peripheral artery disease (PAD) is one of the most frequent manifestations of atherosclerosis
with high rates of morbidity and mortality. Platelets and coagulation are involved in the …

Peripheral artery disease (PAD) affects over 200 million people globally and is a cause of
significant morbidity, mortality, and disability due to limb loss. Although secondary …

Peripheral arterial disease can cause devastating health outcomes, and few therapies are
available to treat this condition. Results of a secondary analysis of the COMPASS trial …

Patients with peripheral artery disease (PAD) are at an increased risk of major adverse
cardiovascular events, and those with disease in the lower extremities are at risk of major …

Rivaroxaban alone did not demonstrate a significant reduction in major adverse
cardiovascular events. Therefore, the combination of rivaroxaban and aspirin appears to be …

Purpose of review Peripheral arterial disease (PAD) is a complex atherosclerotic arterial
disease with significant morbidity and mortality. Hence, the role of evidence-based medical …

Patients with peripheral arterial disease (PAD) are at high risk of both major adverse cardiac
events (MACE) as well as major adverse limb events (MALE), such as severe limb …

Background Patients with peripheral arterial disease (PAD) are at increased risk for major
adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction …